AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0

Voglow GM 1mg/500mg/0.2mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Primus Remedies Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Voglow GM 1mg/500mg/0.2mg Tablet PR

Diabetace-GM, a triple-combination antidiabetic medication (1mg/500mg/0.2mg), is indicated for adult-onset type 2 diabetes management. This formulation helps regulate blood glucose levels. Administer Diabetace-GM with meals, consistently at the same time daily for optimal efficacy. Dosage adjustments are determined by your physician based on blood glucose monitoring and treatment response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation may elevate glucose levels, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, Diabetace-GM is one component of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect; learn to recognize its symptoms (sweating, dizziness, headache, tremors) and implement appropriate countermeasures (fast-acting glucose sources). Alcohol consumption should be limited due to its hypoglycemic potential. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, visual disturbances, bone fractures, and upper respiratory infections. Weight gain may occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are necessary.

Uses of Voglow GM 1mg/500mg/0.2mg Tablet PR

Managing type 2 diabetes

Major Benefits of Voglow GM 1mg/500mg/0.2mg Tablet PR:

Follow your doctor's instructions or consult the product label for guidance before administering. Take Voglow GM 1mg/500mg/0.2mg Tablet PR on an empty stomach.

Common Side effects of Voglow GM 1mg/500mg/0.2mg Tablet PR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Voglow GM 1mg/500mg/0.2mg Tablet PR:

Follow your physician's instructions or consult the product label for usage guidance. Administer Voglow GM 1mg/500mg/0.2mg Tablet PR on an empty stomach.

How Voglow GM 1mg/500mg/0.2mg Tablet PR works:

Voglow GM tablets (1mg/500mg/0.2mg) are a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Voglow GM 1mg/500mg/0.2mg Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Voglow GM 1mg/500mg/0.2mg Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Voglow GM 1mg/500mg/0.2mg Tablet PR while breastfeeding is likely inadvisable. Available evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar fluctuations.

KidneyKidneyUNSAFE

Patients with kidney impairment should likely avoid Voglow GM 1mg/500mg/0.2mg Tablet PR due to potential safety concerns. Medical advice is recommended. The use of Voglow GM 1mg/500mg/0.2mg Tablet PR is discouraged for individuals with severe kidney disease.

LiverLiverCAUTION

Exercise caution when administering Voglow GM 1mg/500mg/0.2mg Tablet PR to individuals with hepatic impairment. Dosage modification of Voglow GM 1mg/500mg/0.2mg Tablet PR may be necessary. Physician consultation is advised. In patients exhibiting mild to moderate liver dysfunction, initiate Voglow GM 1mg/500mg/0.2mg Tablet PR therapy with a reduced starting dose; its use is contraindicated in those with severe liver disease.

What if you forget to take Voglow GM 1mg/500mg/0.2mg Tablet PR :

Should you forget a dose of Voglow GM 1mg/500mg/0.2mg Tablet PR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voglow GM 1mg/500mg/0.2mg Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Voglow GM 1mg/500mg/0.2mg Tablet PR

Voglow GM, a combined tablet containing glimepiride, metformin, and voglibose, treats type 2 diabetes mellitus in adults. It improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This combination is unsuitable for type 1 diabetes.
Voglow GM 1mg/500mg/0.2mg Tablet PR may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste, flatulence, abdominal pain, headache, rash, and respiratory infection.
Voglow GM 1mg/500mg/0.2mg Tablet PR is contraindicated in patients allergic to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Voglow GM 1mg/500mg/0.2mg Tablet PR with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Voglow GM 1mg/500mg/0.2mg Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Voglow GM 1mg/500mg/0.2mg...
98
MRP 119
17% off